Kidney Transplant

An assessment of the 25-year risk of end-stage kidney disease among living kidney donors revealed different risks for different groups of donors, according to data presented at the American Transplant Congress.

In this video, Philippe Gauthier, MD, a transplant nephrologist and senior medical director of organ health at Natera, discusses a two-threshold algorithm that uses donor-derived cell-free DNA and quantity to detect transplant rejection.

Among kidney transplant recipients with uncontrolled gout, pegloticase showed sustained decreased serum urate levels, according to findings presented at the American Transplant Congress.

A second kidney transplant correlates with better survival compared with dialysis treatment, according to data published in the American Journal of Transplantation.

Memo Therapeutics AG announced the initiation of a phase 1 clinical study to examine MTX-005 against BK polyomavirus infection among kidney transplant patients.

The American Kidney Fund has activated its Disaster Relief Program to provide emergency grants of $250 for dialysis and post-transplant patients who live within 50 miles of an active wildfire in New Mexico.

Although COVID-19 vaccines lower the risk of infection among kidney transplant recipients, breakthrough infections can occur, and researchers recommend patients continue to receive boosters when available.

CMS has released a proposed rule setting eligibility requirements for a new law offering immunosuppressive drug coverage for more patients with a kidney transplant.

The American Kidney Fund announced its support for the passing of S.B. 218, which helps protect living donors in Delaware.

Kidney transplant patients infected with COVID-19, including the omicron variant, benefit from neutralizing monoclonal antibody therapy, according to data published in Kidney Medicine.